TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Urolift Consumables

Urology
exploration devices
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Chelsea & Westminster Hospital NHS Foundation Trusts: "Urolift Consumables". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityChelsea & Westminster Hospital NHS Foundation TrustsScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Chelsea & Westminster Hospital NHS Foundation Trusts
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Chelsea & Westminster Hospital NHS Foundation Trusts. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityChelsea & Westminster Hospital NHS Foundation Trusts
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published19 Jul 2021, 13:59 BST
Last source update19 Jul 2021, 13:59 BST
Recurring procurementNot published
ClassificationUrology, exploration devices
Delivery area
UK
OCIDocds-h6vhtk-02c98e
What is being bought
Benign prostatic hyperplasia affects over 500 million men worldwide. While men can select from a variety of treatment options—from medication to major surgery—there has been a gap in the treatment continuum for a less invasive option. Prostatic Urethral Lift using the UroLift® System was designed to meet this need. With its unique design and mechanism of action, the UroLift System is a straightforward treatment that provides immediate, visible results. The procedure can be done in an outpatient or inpatient setting and under general or local anaesthesia. Patients typically can return home the same day without a catheter, and experience rapid symptom relief and recovery with low complication rates. The UroLift System treatment revitalizes the quality of life for patients and improves the BPH therapy experience for physicians.
What changed
From the official release history
  1. Status changed to complete
    19 Jul 2021, 13:59 BST
  2. Official notice release published
    19 Jul 2021, 13:59 BST
  3. Buyer information updated
    19 Jul 2021, 13:59 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Purchase of 60 boxes pa of Urolift UL400-4 devices over the life of the contract... Each box consists of 4 units.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    19 Jul 2021, 13:59 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 19 Jul 2021, 00:00 BST · Not published
Commercial outcome and competition
Awards
Teleflex Medical
Not published · Not published · active
Contracts
Contract
Not published · signed 19 Jul 2021, 00:00 BST · active
Bid statistics
highestValidBidValue: 350000
lowestValidBidValue: 150000
highestValidBidValue: 350000 (lot 1)
lowestValidBidValue: 150000 (lot 1)
Buyer and organisations in this procedure

Chelsea & Westminster Hospital NHS Foundation Trusts

Contracting authority GB-FTS-22820
View buyer profile

  • Chelsea & Westminster Hospital NHS Foundation Trusts
    buyer

    Unit G2, Harbour Yard, Chelsea Harbour, London, UK, SW10 0XD
    chelwest.tenders@nhs.net

  • High Court
    reviewBody

    The Strand, London, WC2 A2LL

  • Teleflex Medical
    supplier

    Grosvenor House 7 Horseshoe Crescent, Beaconsfield, Beaconsfield, UK, HP9 1LLJ
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleAward of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below • The procurement falls outside the scope of application of the directive Explanation: The Trust is seeking an Innovative Prostatic Stapling Implant system in place of the invasive transuretheral resection of prostrate (TURP) Patients benefit by this system in the following ways: - This is a Day case procedure with less blood loss and reduced possibility of transfusion. - Better patience experience as this procedure is better tolerated by younger patients. - Day case means patient can go home quickly And the Trust benefits in the following ways: - The release of release bed capacity on the Surgical Short Stay Ward. -Reduction in cost associated with day case -Increase in Trust reputation for undertaking Innovative procedures And the Urolift System is the only product in the market which delivers the combined benefit to the Patients and the Trust.